Market Cap 122.89B
Revenue (ttm) 33.54B
Net Income (ttm) 4.66B
EPS (ttm) N/A
PE Ratio 17.25
Forward PE 16.95
Profit Margin 13.90%
Debt to Equity Ratio 0.59
Volume 6,227,907
Avg Vol 6,723,236
Day's Range N/A - N/A
Shares Out 1.28B
Stochastic %K 93%
Beta 0.77
Analysts Sell
Price Target $101.54

Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic va...

Industry: Medical Devices
Sector: Healthcare
Phone: 353 1 438 1700
Address:
Building Two, Parkmore Business Park West, Galway, Ireland
THE_Perfusionist
THE_Perfusionist Nov. 14 at 2:34 AM
For those in the back…these companies like $MDT and $LIVN are rocking the ECMO world. $IINN not so much.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:45 PM
JP Morgan has adjusted their stance on Medtronic ( $MDT ), setting the rating to Neutral with a target price of 90 → 100.
0 · Reply
GettnFibbywIT
GettnFibbywIT Nov. 12 at 8:36 PM
$MDT $XLV $IHI Medtronic (MDT) / Daily - Price popping back up again into the former rising price channel after retracing to/bouncing up from a 50% fib level...Let's see if the bullish price action can hold/move up from here:
0 · Reply
AllenSteir976
AllenSteir976 Nov. 12 at 3:09 PM
$MDT innovates in medical devices and surgical robotics, sustaining long-term growth through R&D investment. AERT recently turned profitable in Q2 FY2026, reporting $17.36 M revenue and $0.64 M net income, highlighting momentum in its AI-led global delivery model. https://www.youtube.com/watch?v=d2BieklTnl4
0 · Reply
ZacksResearch
ZacksResearch Nov. 12 at 1:13 PM
$MDT earnings preview: Will the MedTech giant maintain its earnings performance? 🏆 📈 Cardiovascular segment expected to shine with an 8.4% revenue growth YoY, thanks to strong uptake of key systems. 🧠 Neuroscience unit expected to grow 1.5% YoY, while Medical Surgical is estimated to see a 5.4% increase. 📊 Diabetes unit shows momentum, fueled by advanced tech and FDA milestones. Discover if MDT can continue its earnings performance here 👉 https://www.zacks.com/stock/news/2789764/mdt-q2-earnings-preview-cardiovascular-unit-likely-to-boost-growth?cid=sm-stocktwits-2-2789764-body-20653&ADID=SYND_STOCKTWITS_TWEET_2_2789764_BODY_20653
0 · Reply
ZacksResearch
ZacksResearch Nov. 12 at 12:13 PM
$MDT Q2 earnings could get a heartbeat boost ❤️‍🔥 Growth may be driven by strength in the cardiovascular unit, which is expected to lift overall performance this quarter. Find out what to watch in Medtronic’s Q2 report 👉 https://www.zacks.com/stock/news/2789764/mdt-q2-earnings-preview-cardiovascular-unit-likely-to-boost-growth?cid=sm-stocktwits-2-2789764-teaser-20651&ADID=SYND_STOCKTWITS_TWEET_2_2789764_TEASER_20651
0 · Reply
JasonCO
JasonCO Nov. 12 at 12:12 PM
$MDT nice move off $89’s.
0 · Reply
peter
peter Nov. 12 at 11:52 AM
Closed long position on $MDT at $91.50.
1 · Reply
roblake29
roblake29 Nov. 11 at 10:44 PM
$MDT My latest analysis of this fine company. https://seekingalpha.com/article/4842066-medtronic-possible-earnings-beat-incoming-but-still-overvalued
0 · Reply
TraderJoeGettinDough
TraderJoeGettinDough Nov. 11 at 3:33 PM
$MDT is the 200 day finally going to be a strong support? Bounced right off that bih
0 · Reply
Latest News on MDT
Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 13 days ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Medtronic: A Revitalized Dividend Aristocrat To Buy Now

Oct 26, 2025, 12:12 PM EDT - 19 days ago

Medtronic: A Revitalized Dividend Aristocrat To Buy Now


Medtronic Stock's $50 Billion Gift To Investors

Oct 13, 2025, 6:45 AM EDT - 4 weeks ago

Medtronic Stock's $50 Billion Gift To Investors


Medtronic plc - Special Call

Oct 9, 2025, 2:56 PM EDT - 5 weeks ago

Medtronic plc - Special Call


Medtronic: FY26 Outlook Strengthened By New Product Launches

Sep 25, 2025, 8:13 AM EDT - 7 weeks ago

Medtronic: FY26 Outlook Strengthened By New Product Launches


Medtronic: Buy This Dividend Aristocrat While It's Good Value

Sep 17, 2025, 11:59 AM EDT - 2 months ago

Medtronic: Buy This Dividend Aristocrat While It's Good Value


Medtronic Announces Pricing of €1.5 Billion of Senior Notes

Sep 15, 2025, 5:41 PM EDT - 2 months ago

Medtronic Announces Pricing of €1.5 Billion of Senior Notes


Medtronic executives to speak at upcoming investor conferences

Aug 29, 2025, 11:22 AM EDT - 2 months ago

Medtronic executives to speak at upcoming investor conferences


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 2 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


Medtronic: Earnings Are Solid, New Board Additions Add Intrigue

Aug 21, 2025, 2:02 PM EDT - 3 months ago

Medtronic: Earnings Are Solid, New Board Additions Add Intrigue


Medtronic Has Potential To Pursue Further Divestitures: Analyst

Aug 20, 2025, 1:15 PM EDT - 3 months ago

Medtronic Has Potential To Pursue Further Divestitures: Analyst


Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings

Aug 19, 2025, 1:11 PM EDT - 3 months ago

Nasdaq Down Over 300 Points; Medtronic Posts Upbeat Earnings


Activist investor Elliott push spurs changes at Medtronic

Aug 19, 2025, 11:32 AM EDT - 3 months ago

Activist investor Elliott push spurs changes at Medtronic


Medtronic plc (MDT) Q1 2026 Earnings Call Transcript

Aug 19, 2025, 11:19 AM EDT - 3 months ago

Medtronic plc (MDT) Q1 2026 Earnings Call Transcript


Medtronic raises annual profit forecast on lower tariff impact

Aug 19, 2025, 6:48 AM EDT - 3 months ago

Medtronic raises annual profit forecast on lower tariff impact


Medtronic reports first quarter fiscal 2026 financial results

Aug 19, 2025, 6:45 AM EDT - 3 months ago

Medtronic reports first quarter fiscal 2026 financial results


Medtronic to Add Directors After Elliott Becomes Big Shareholder

Aug 19, 2025, 5:45 AM EDT - 3 months ago

Medtronic to Add Directors After Elliott Becomes Big Shareholder


Buy or Sell Medtronic Stock Now?

Aug 18, 2025, 10:05 AM EDT - 3 months ago

Buy or Sell Medtronic Stock Now?


THE_Perfusionist
THE_Perfusionist Nov. 14 at 2:34 AM
For those in the back…these companies like $MDT and $LIVN are rocking the ECMO world. $IINN not so much.
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 6:45 PM
JP Morgan has adjusted their stance on Medtronic ( $MDT ), setting the rating to Neutral with a target price of 90 → 100.
0 · Reply
GettnFibbywIT
GettnFibbywIT Nov. 12 at 8:36 PM
$MDT $XLV $IHI Medtronic (MDT) / Daily - Price popping back up again into the former rising price channel after retracing to/bouncing up from a 50% fib level...Let's see if the bullish price action can hold/move up from here:
0 · Reply
AllenSteir976
AllenSteir976 Nov. 12 at 3:09 PM
$MDT innovates in medical devices and surgical robotics, sustaining long-term growth through R&D investment. AERT recently turned profitable in Q2 FY2026, reporting $17.36 M revenue and $0.64 M net income, highlighting momentum in its AI-led global delivery model. https://www.youtube.com/watch?v=d2BieklTnl4
0 · Reply
ZacksResearch
ZacksResearch Nov. 12 at 1:13 PM
$MDT earnings preview: Will the MedTech giant maintain its earnings performance? 🏆 📈 Cardiovascular segment expected to shine with an 8.4% revenue growth YoY, thanks to strong uptake of key systems. 🧠 Neuroscience unit expected to grow 1.5% YoY, while Medical Surgical is estimated to see a 5.4% increase. 📊 Diabetes unit shows momentum, fueled by advanced tech and FDA milestones. Discover if MDT can continue its earnings performance here 👉 https://www.zacks.com/stock/news/2789764/mdt-q2-earnings-preview-cardiovascular-unit-likely-to-boost-growth?cid=sm-stocktwits-2-2789764-body-20653&ADID=SYND_STOCKTWITS_TWEET_2_2789764_BODY_20653
0 · Reply
ZacksResearch
ZacksResearch Nov. 12 at 12:13 PM
$MDT Q2 earnings could get a heartbeat boost ❤️‍🔥 Growth may be driven by strength in the cardiovascular unit, which is expected to lift overall performance this quarter. Find out what to watch in Medtronic’s Q2 report 👉 https://www.zacks.com/stock/news/2789764/mdt-q2-earnings-preview-cardiovascular-unit-likely-to-boost-growth?cid=sm-stocktwits-2-2789764-teaser-20651&ADID=SYND_STOCKTWITS_TWEET_2_2789764_TEASER_20651
0 · Reply
JasonCO
JasonCO Nov. 12 at 12:12 PM
$MDT nice move off $89’s.
0 · Reply
peter
peter Nov. 12 at 11:52 AM
Closed long position on $MDT at $91.50.
1 · Reply
roblake29
roblake29 Nov. 11 at 10:44 PM
$MDT My latest analysis of this fine company. https://seekingalpha.com/article/4842066-medtronic-possible-earnings-beat-incoming-but-still-overvalued
0 · Reply
TraderJoeGettinDough
TraderJoeGettinDough Nov. 11 at 3:33 PM
$MDT is the 200 day finally going to be a strong support? Bounced right off that bih
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 7 at 9:35 PM
🎯 Target Hit 🏁 📨 From Oct 29, 2025 🏛️ $MDT 💵 Entry: $92.3000 ✅ Exit: $94.6721 💰 P/L: +2.57% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
SBAlpha
SBAlpha Nov. 7 at 5:58 PM
0 · Reply
AlphaByAI
AlphaByAI Nov. 7 at 5:41 PM
$MDT $ABT $BSX $SYK $JNJ A deep dive into five large-cap US Medical Devices stocks. https://newsletter.ai-wk.com/p/us-medical-devices-watchlist
0 · Reply
frontiere
frontiere Nov. 7 at 5:32 PM
$ADGM Adagio Medical ref=$0.93 — big Long. Comp $MDT Medtronic PLSE Pulse etc — but trading is about taking an asymmetric risk:reward bet, and ADGM here seems highly skewed in favor of a long swing after raising just weeks ago with $1.71 and $1.94 wrt EPs. Trading deep under cash (MCap<Cash), shares outst=21m as of 2025-10-24 per Proxy. 👍Catalyst in 1H 2026 readout Fulcrum-VT open label 👍 (prelim acute readout already PR’ed 10 Oct https://investors.adagiomedical.com/news-releases/news-release-details/adagio-medical-unveils-preliminary-acute-results-fulcrum-vt-us ) ClinTrial for Cryoablation for Monomorphic Ventricular Tachycardia (FULCRUM-VT) last upd 2025-01-29 https://clinicaltrials.gov/study/NCT05675865?term=Adagio%20fulcrum-vt&rank=1 Proxy for Shareholder meeting 2025-12-15 https://www.sec.gov/Archives/edgar/data/2006986/000114036125040334/edge20056107x1_def14a.htm#tSO Corp deck Aug 2025 https://investors.adagiomedical.com/static-files/e584b8e3-071c-45a7-b31a-186d2bd38aee
1 · Reply
daniel_foster88
daniel_foster88 Nov. 7 at 11:29 AM
$MDT reclaim $80, target $82.
0 · Reply
LongDuckDongFever2020
LongDuckDongFever2020 Nov. 6 at 5:13 PM
$MDT major disconnect with $SPHL ran with MDT to .80. now .60
0 · Reply
RunnerSignals
RunnerSignals Nov. 4 at 4:26 AM
$JHG $MDT $TEF crossed the death line today 💀 200-DMA breaks aren't pretty. Time to step aside or buy the dip? Charts don't lie
1 · Reply
clarkstocks
clarkstocks Nov. 4 at 1:38 AM
$RIVN I started work for a company that makes machines for testing electronics. We make testers for the motors and other parts like the infotainment system for rivian. They just ordered 16 more testers. Last quarter they got 4. Huge increase. Makes me bullish! Also dump all your $MDT stock unless you love h1b's
0 · Reply
JasonCO
JasonCO Nov. 3 at 5:24 PM
$MDT watching
0 · Reply
Mastercluster
Mastercluster Nov. 3 at 1:15 PM
$MDT Will It drop Below 90 $ today.
1 · Reply
clan
clan Nov. 3 at 8:23 AM
$MNKD How about a deal with any (or multiple) CGM maker(s)? Afrezza + a CGM = best Time In Range (TIR). All CGM makers [ $DXCM $SENS $MDT $ABT ] should want to be hangin' with the cool kids {who are inhaling}.
0 · Reply
vitomarshall7
vitomarshall7 Nov. 1 at 12:10 AM
$HOOD $MDT Foaming themes https://stocktwits.com/joshuaemerson/message/634561644
0 · Reply